RxDoctor Payments Data

Marianne Dait, DO

Family Medicine · Hayes, VANPI 1962418947

Payments from drug & device makers

$612in general payments, 2019–2025

Across 31 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$197
  • Novo Nordisk$119
  • Pfizer$51
  • GSK$46
  • AstraZeneca$42
  • Biohaven Pharmaceuticals, Inc.$29
  • plus $127 from 7 others

What the payments were for

  • Food & beverage$59397%
  • Education$193%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$612 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$204,457
Medicare patients
274
Services billed
5,418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin84$120,626
EliquisApixaban81$70,957
RybelsusSemaglutide29$44,598
XareltoRivaroxaban32$39,676
JanuviaSitagliptin Phosphate31$33,453
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,583
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$9,358
Synjardy XrEmpagliflozin/Metformin Hcl13$7,512
Combivent RespimatIpratropium/Albuterol Sulfate14$6,648
Atorvastatin Calcium585$5,985
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$4,851
Duloxetine Hcl97$3,476
Albuterol Sulfate HfaAlbuterol Sulfate128$2,771
Rosuvastatin Calcium271$2,625
Metoprolol Succinate143$2,003

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Combivent Respimat$19$134,786111 claims
PfizerEliquis$51$70,95781 claims
Novo NordiskRybelsus$119$44,59829 claims
Johnson & JohnsonXarelto$14$39,67632 claims
GSKTrelegy Ellipta, Anoro Ellipta$46$23,94137 claims
AbbVieSynthroid$24$1,56524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Hayes

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →